Black Diamond Therapeutics, Inc. (BDTX)

BDTX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.07	20.99	36.44	56.22	34.32	65.8
Short-Term Investments	88.19	107.66	62.14	75.18	88.49	143.99
Cash & Short-Term Investments	118.26	128.65	98.58	131.4	122.81	209.79
Cash Growth	-22.40%	30.51%	-24.98%	7.00%	-41.46%	-33.41%
Other Current Assets	4.71	3.79	2.6	2.63	4.9	5.92
Total Current Assets	122.97	132.44	101.18	134.03	127.71	215.7
Net Property, Plant & Equipment	9.1	9.67	20.4	23.71	27.38	30.74
Other Long-Term Assets	0.86	0.9	1.07	0.82	1.17	1.24
Total Assets	132.92	143.01	122.64	158.57	156.26	247.68
Accounts Payable	2.97	0.58	4.01	2.32	1.88	4.11
Accrued Expenses	11.57	15.15	16.57	17.32	13.38	19.54
Total Current Liabilities	14.53	15.73	20.57	19.65	15.26	23.64
Long-Term Leases	14.09	15.07	18.78	22.19	25.3	28.14
Total Long-Term Liabilities	14.09	15.07	18.78	22.19	25.3	28.14
Total Liabilities	28.62	30.8	39.36	41.83	40.56	51.78
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	578.1	576.84	570.36	534.19	452.5	440.13
Accumulated Other Comprehensive Income	-0.04	0.1	0.02	-0.03	-1.82	-0.41
Retained Earnings	-473.78	-464.74	-487.11	-417.43	-334.99	-243.82
Shareholders' Equity	104.3	112.21	83.29	116.74	115.7	195.9
Total Liabilities & Equity	132.92	143.01	122.64	158.57	156.26	247.68
Total Debt	14.09	15.07	18.78	22.19	25.3	28.14
Net Cash (Debt)	104.17	113.58	79.79	109.22	97.51	181.65
Net Cash Growth	-8.29%	42.35%	-26.94%	12.01%	-46.32%	-40.90%
Net Cash Per Share	1.83	1.97	1.45	2.48	2.68	5.02
Book Value	104.3	112.21	83.29	116.74	115.7	195.9
Book Value Per Share	1.83	1.95	1.51	2.66	3.18	5.41
Tangible Book Value	104.3	112.21	83.29	116.74	115.7	195.9
Tangible Book Value Per Share	1.83	1.95	1.51	2.66	3.18	5.41

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q